Over the short 25.4-month median follow-up period, we observed that gastric cancer patients with moderate/strong CCAR1 expression had a poorer prognosis than those with negative/weak CCAR1 expression, but did not meet statistical significance. Here, CCAR1 is linked to gastric cancer.